Today’s Price Action: What’s in Bioamber Inc After Today’s Big Increase?

Today's Price Action: What's in Bioamber Inc After Today's Big Increase?

The stock of Bioamber Inc (NYSE:BIOA) is a huge mover today! The stock increased 6.14% or $0.36 on November 23, hitting $6.22. About 347,613 shares traded hands or 196.35% up from the average. Bioamber Inc (NYSE:BIOA) has risen 33.76% since April 22, 2016 and is uptrending. It has outperformed by 28.35% the S&P500.
The move comes after 8 months positive chart setup for the $165.26M company. It was reported on Nov, 24 by We have $6.59 PT which if reached, will make NYSE:BIOA worth $9.92 million more.

Analysts await Bioamber Inc (NYSE:BIOA) to report earnings on March, 13. They expect $-0.20 earnings per share, up 50.00% or $0.20 from last year’s $-0.4 per share. After $-0.26 actual earnings per share reported by Bioamber Inc for the previous quarter, Wall Street now forecasts -23.08% EPS growth.

According to Zacks Investment Research, “BioAmber Inc. is a bio-based chemicals company. It produces and sells bio-succinic acid. The company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in products including plastics, resins, food additives and personal care products. It operates in France, China, Canada, and the United States. BioAmber Inc. is based in Plymouth, Minnesota.”

Insitutional Activity: The institutional sentiment increased to 1.5 in Q2 2016. Its up 0.68, from 0.82 in 2016Q1. The ratio improved, as 2 funds sold all Bioamber Inc shares owned while 9 reduced positions. 1 funds bought stakes while 8 increased positions. They now own 11.17 million shares or 8.33% less from 12.19 million shares in 2016Q1.
Raymond James Financial Serv Advisors last reported 0% of its portfolio in the stock. Blackrock Fund last reported 0% of its portfolio in the stock. Geode Cap Management Ltd Limited Liability Company holds 75,464 shares or 0% of its portfolio. Northern Trust Corporation holds 0% or 22,349 shares in its portfolio. Lpl Finance holds 0% of its portfolio in Bioamber Inc (NYSE:BIOA) for 41,450 shares. Scotia has 0% invested in the company for 14,850 shares. The New York-based Goldman Sachs Grp Inc Inc has invested 0% in Bioamber Inc (NYSE:BIOA). Bancshares Of America De accumulated 3,537 shares or 0% of the stock. Blackrock Institutional Trust Na holds 0% or 137,711 shares in its portfolio. Moreover, Tower Rech Limited Liability Company (Trc) has 0% invested in Bioamber Inc (NYSE:BIOA) for 1,752 shares. Baillie Gifford last reported 0% of its portfolio in the stock. Moreover, Deutsche Bank Ag has 0% invested in Bioamber Inc (NYSE:BIOA) for 294,216 shares. Federated Invsts Inc Pa accumulated 0% or 250,574 shares. Commercial Bank Of Ny Mellon Corp reported 15,311 shares or 0% of all its holdings. The Ontario – Canada-based Toronto Dominion Bankshares has invested 0% in Bioamber Inc (NYSE:BIOA).

Insider Transactions: Since November 8, 2016, the stock had 2 buys, and 0 insider sales for $135,045 net activity. On Tuesday, November 8 BRINER KURT W bought $38,415 worth of the stock or 10,000 shares. The insider Gosbee George Frederick John bought 25,000 shares worth $96,630.

Another recent and important Bioamber Inc (NYSE:BIOA) news was published by which published an article titled: “BioAmber Inc. BIOA (US: NYSE)” on April 27, 2013.

BIOA Company Profile

BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., incorporated on October 15, 2008, is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, resins, food additives and personal care products. The Company’s geographical divisions include Europe and North America. The Firm sells its product, bio-succinic acid, to clients in a range of chemical markets. Bio-succinic acid is a biologically produced, chemically identical replacement for petroleum-derived succinic acid that can be utilized to produce derivative products, such as bio 1,4 Butanediol (1,4 BDO), and can substitute petrochemicals, such as maleic anhydride, phthalic acid and adipic acid in various applications. The Company’s bio specialty chemicals can be used in multiple end-markets and applications, and serves as building blocks for a range of products used every day. Bio-succinic acid is used in various applications, including plasticizers, polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals and lubricants, as well as anti-freeze solutions, coolants solvents, water treatment chemicals, laundry tablets and bath salts, artificial leather products, and foams made with recycled polyethylene terephthalate (PET).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment